Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Noveida

- PMLiVE

Europe responding to gene therapy challenge, but picture remains fragmented

Germany, Italy and England using outcomes-based deals

- PMLiVE

Vertex chief Jeffrey Leiden to weigh in on Orkambi inquiry

Will be joined by chief commercial officer Stuart Arbuckle

- PMLiVE

‘Inflexible’ NICE blocking access to rare disease drugs

Spinraza most high profile example of access problem

- PMLiVE

Industry concerned about ‘rushed’ Brexit withdrawal legislation

The Patents Amendment could weaken the UK’s IP framework, warns biopharma

- PMLiVE

Beneluxa: the future of European market access?

Andrew McConaghie talks to Beneluxa’s Marcel van Raaij and Biogen’s Erik Smet about their groundbreaking deal on Spinraza and what it means for European market access

- PMLiVE

Digital applications are transforming the market access landscape

Optimising product value through digital technology

The European Medicines Agency: PRIME’d for access?

Leela Barham examines the impact of the EMA's PRIME fast track system after two years

Live from Singapore: Full speed ahead – Unlock the full potential of your brand tracking

Thursday 28th June 16:00 SGT/ 16:00 CST / 17:00 JST

Research Partnership

- PMLiVE

Understanding HCPs to build a meaningful brand

In the regulated world of pharmaceutical marketing,  how can a brand build a meaningful relationship with its customers? This article explores healthcare professionals’ (HCPs) perceptions of pharmaceutical companies, using analysis of...

Segmentation, evolved

My research into the evolution of the life science industry reveals broad, sweeping trends, as I wrote about in previous PME articles such as “Selection Pressures” and “Explosive Evolution”. But...

International digital pharma marketing: 10 common problems

Your digital marketing challenges are probably shared by peers in other departments and companies. The good news is that such problems often have simple solutions, or can be avoided completely...

Anthill Agency

Digital pharma marketing: 5 ways to avoid localisation problems

Localisation of digital materials isn’t difficult but it can go wrong. Here’s how to keep everything on track.

Anthill Agency

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links